516 related articles for article (PubMed ID: 26439325)
1. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
2. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.
Shaw BE; Flynn KE; He N; Cusatis R; D'Souza A; Hamilton BK; Horowitz MM; Mattila D; Phelan R; Lee SJ; Brazauskas R
Cancer; 2024 May; 130(10):1826-1835. PubMed ID: 38198511
[TBL] [Abstract][Full Text] [Related]
5. Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.
Jacobsen PB; Le-Rademacher J; Jim H; Syrjala K; Wingard JR; Logan B; Wu J; Majhail NS; Wood W; Rizzo JD; Geller NL; Kitko C; Faber E; Abidi MH; Slater S; Horowitz MM; Lee SJ
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1530-6. PubMed ID: 24910380
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
7. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
9. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.
Sorror ML; Logan BR; Zhu X; Rizzo JD; Cooke KR; McCarthy PL; Ho VT; Horowitz MM; Pasquini MC
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1479-87. PubMed ID: 25862591
[TBL] [Abstract][Full Text] [Related]
10. Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study.
Devins GM; Mah K; Messner HA; Xenocostas A; Gauvin L; Lipton JH
Support Care Cancer; 2018 Jul; 26(7):2379-2386. PubMed ID: 29423678
[TBL] [Abstract][Full Text] [Related]
11. Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902).
Wingard JR; Wood WA; Martens M; Le-Rademacher J; Logan B; Knight JM; Jacobsen PB; Jim H; Majhail NS; Syrjala K; Rizzo JD; Lee SJ
Biol Blood Marrow Transplant; 2017 Jan; 23(1):161-164. PubMed ID: 27742574
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.
Hamilton BK; Law AD; Rybicki L; Abounader D; Dabney J; Dean R; Duong HK; Gerds AT; Hanna R; Hill BT; Jagadeesh D; Kalaycio ME; Lawrence C; McLellan L; Pohlman B; Sobecks RM; Bolwell BJ; Majhail NS
Bone Marrow Transplant; 2015 Sep; 50(9):1235-40. PubMed ID: 26030045
[TBL] [Abstract][Full Text] [Related]
13. The Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.
Shibasaki Y; Suwabe T; Katagiri T; Tanaka T; Kobayashi H; Fuse K; Ushiki T; Sato N; Yano T; Kuroha T; Hashimoto S; Narita M; Furukawa T; Sone H; Masuko M
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28871665
[TBL] [Abstract][Full Text] [Related]
14. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Hong S; Brazauskas R; Hebert KM; Ganguly S; Abdel-Azim H; Diaz MA; Beattie S; Ciurea SO; Szwajcer D; Badawy SM; Gratwohl AA; LeMaistre C; Aljurf MDSM; Olsson RF; Bhatt NS; Farhadfar N; Yared JA; Yoshimi A; Seo S; Gergis U; Beitinjaneh AM; Sharma A; Lazarus H; Law J; Ulrickson M; Hashem H; Schoemans H; Cerny J; Rizzieri D; Savani BN; Kamble RT; Shaw BE; Khera N; Wood WA; Hashmi S; Hahn T; Lee SJ; Rizzo JD; Majhail NS; Saber W
Cancer; 2021 Feb; 127(4):609-618. PubMed ID: 33085090
[TBL] [Abstract][Full Text] [Related]
15. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
[TBL] [Abstract][Full Text] [Related]
16. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.
Wood WA; Deal AM; Abernethy A; Basch E; Battaglini C; Kim YH; Whitley J; Shatten C; Serody J; Shea T; Reeve BB
Biol Blood Marrow Transplant; 2013 Mar; 19(3):450-9. PubMed ID: 23253558
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study.
Wood WA; Deal AM; Reeve BB; Abernethy AP; Basch E; Mitchell SA; Shatten C; Hie Kim Y; Whitley J; Serody JS; Shea T; Battaglini C
Bone Marrow Transplant; 2013 Oct; 48(10):1342-9. PubMed ID: 23584437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
